Somatic evolution in cancer

Preventing lung cancer's unwelcome return

Retrieved on: 
Tuesday, July 13, 2021
Branches of biology, Cancer, Clinical medicine, Lung cancer, Oncology, Epidermal growth factor receptor, Oncogenes, Non-small-cell lung carcinoma, Brachyury, Neoplasm, KRAS, Somatic evolution in cancer

Cold Spring Harbor Laboratory (CSHL) Visiting Scientist Raffaella Sordella investigated a similar problem that occurs in some lung cancers .

Key Points: 
  • Cold Spring Harbor Laboratory (CSHL) Visiting Scientist Raffaella Sordella investigated a similar problem that occurs in some lung cancers .
  • Approximately 15% of non-small cell lung cancers have a mutation in a growth receptor called EGFR, causing tumor cells to grow uncontrollably.
  • Researchers developed an effective drug that inhibits EGFR and kills cancer cells, but the tumor grows back later.
  • Understanding how resistance arises in lung cancer is key to figuring out how to eliminate a tumor.

The Growing Demand for Cancer Treatment is Raising Immunotherapy Dependence

Retrieved on: 
Friday, August 31, 2018
Cancer, RTT, Carcinogenesis, Stem cells, Histopathology, Prostate cancer, Breast cancer, Chimeric antigen receptor, Somatic evolution in cancer

The growing demand for technology like DNA sequencing, fermentation, recombinant technology and tissue engineering is expected to drive the market.

Key Points: 
  • The growing demand for technology like DNA sequencing, fermentation, recombinant technology and tissue engineering is expected to drive the market.
  • The immunotherapy market application segment is broken up into various forms of cancer such as lung cancer, breast cancer, and prostate cancer, which are among the most common forms.
  • The market will see strong growth due to the prevalence of cancer and the rising demand for treatment options.
  • Therapies that manipulate NR2F6 show potential to act as a cancer stem cell differentiators, potentially transforming cancer stem cells into normal cells.